Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO)’s share price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as C$0.20 and last traded at C$0.21, with a volume of 85632 shares changing hands. The stock had previously closed at C$0.26.
Aptose Biosciences Stock Performance
The stock’s 50-day moving average price is C$0.30 and its 200-day moving average price is C$0.44. The company has a debt-to-equity ratio of -117.37, a quick ratio of 5.41 and a current ratio of 1.05. The company has a market capitalization of C$9.04 million, a price-to-earnings ratio of -0.04 and a beta of 1.36.
About Aptose Biosciences
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Read More
- Five stocks we like better than Aptose Biosciences
- Why Are These Companies Considered Blue Chips?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Retail Stocks Investing, Explained
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
